Margaret M. Briehl - Publications

University of Arizona, Tucson, AZ 
Molecular Biology, Oncology, Cell Biology

27 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Jaramillo MC, Briehl MM, Batinic-Haberle I, Tome ME. Manganese (III) meso-tetrakis N-ethylpyridinium-2-yl porphyrin acts as a pro-oxidant to inhibit electron transport chain proteins, modulate bioenergetics, and enhance the response to chemotherapy in lymphoma cells. Free Radical Biology & Medicine. 83: 89-100. PMID 25725417 DOI: 10.1016/j.freeradbiomed.2015.01.031  0.6
2014 Briehl MM, Tome ME, Wilkinson ST, Jaramillo MC, Lee K. Mitochondria and redox homoeostasis as chemotherapeutic targets. Biochemical Society Transactions. 42: 939-44. PMID 25109983 DOI: 10.1042/BST20140087  0.6
2014 Barr PM, Miller TP, Friedberg JW, Peterson DR, Baran AM, Herr M, Spier CM, Cui H, Roe DJ, Persky DO, Casulo C, Littleton J, Schwartz M, Puvvada S, Landowski TH, ... ... Briehl MM, et al. Phase 2 study of imexon, a prooxidant molecule, in relapsed and refractory B-cell non-Hodgkin lymphoma. Blood. 124: 1259-65. PMID 25016003 DOI: 10.1182/blood-2014-04-570044  0.68
2014 Lee K, Hart MR, Briehl MM, Mazar AP, Tome ME. The copper chelator ATN-224 induces caspase-independent cell death in diffuse large B cell lymphoma. International Journal of Oncology. 45: 439-47. PMID 24788952 DOI: 10.3892/ijo.2014.2396  0.6
2014 Gustafson HL, Yao S, Goldman BH, Lee K, Spier CM, LeBlanc ML, Rimsza LM, Cerhan JR, Habermann TM, Link BK, Maurer MJ, Slager SL, Persky DO, Miller TP, Fisher RI, ... ... Briehl MM, et al. Genetic polymorphisms in oxidative stress-related genes are associated with outcomes following treatment for aggressive B-cell non-Hodgkin lymphoma. American Journal of Hematology. 89: 639-45. PMID 24633940 DOI: 10.1002/ajh.23709  0.68
2013 Lee K, Briehl MM, Mazar AP, Batinic-Haberle I, Reboucas JS, Glinsmann-Gibson B, Rimsza LM, Tome ME. The copper chelator ATN-224 induces peroxynitrite-dependent cell death in hematological malignancies. Free Radical Biology & Medicine. 60: 157-67. PMID 23416365 DOI: 10.1016/j.freeradbiomed.2013.02.003  0.6
2012 Wilkinson ST, Tome ME, Briehl MM. Mitochondrial adaptations to oxidative stress confer resistance to apoptosis in lymphoma cells. International Journal of Molecular Sciences. 13: 10212-28. PMID 22949856 DOI: 10.3390/ijms130810212  0.6
2012 Tome ME, Lee K, Jaramillo MC, Briehl MM. Mitochondria are the primary source of the H(2)O(2) signal for glucocorticoid-induced apoptosis of lymphoma cells. Experimental and Therapeutic Medicine. 4: 237-242. PMID 22844350 DOI: 10.3892/etm.2012.595  0.6
2012 Sertel S, Tome M, Briehl MM, Bauer J, Hock K, Plinkert PK, Efferth T. Factors determining sensitivity and resistance of tumor cells to arsenic trioxide. Plos One. 7: e35584. PMID 22590507 DOI: 10.1371/journal.pone.0035584  0.68
2012 Tome ME, Frye JB, Coyle DL, Jacobson EL, Samulitis BK, Dvorak K, Dorr RT, Briehl MM. Lymphoma cells with increased anti-oxidant defenses acquire chemoresistance. Experimental and Therapeutic Medicine. 3: 845-852. PMID 22529877 DOI: 10.3892/etm.2012.487  0.68
2012 Jaramillo MC, Briehl MM, Crapo JD, Batinic-Haberle I, Tome ME. Manganese porphyrin, MnTE-2-PyP 5+, acts as a pro-oxidant to potentiate glucocorticoid-induced apoptosis in lymphoma cells Free Radical Biology and Medicine. 52: 1272-1284. PMID 22330065 DOI: 10.1016/j.freeradbiomed.2012.02.001  0.68
2011 Tome ME, Jaramillo MC, Briehl MM. Hydrogen peroxide signaling is required for glucocorticoid-induced apoptosis in lymphoma cells. Free Radical Biology & Medicine. 51: 2048-59. PMID 21964507 DOI: 10.1016/j.freeradbiomed.2011.09.002  0.6
2010 Wilkinson ST, Johnson DB, Tardif HL, Tome ME, Briehl MM. Increased cytochrome c correlates with poor survival in aggressive lymphoma. Oncology Letters. 1: 227-230. PMID 20798784 DOI: 10.3892/ol_00000040  0.6
2009 Skalska J, Brookes PS, Nadtochiy SM, Hilchey SP, Jordan CT, Guzman ML, Maggirwar SB, Briehl MM, Bernstein SH. Modulation of cell surface protein free thiols: a potential novel mechanism of action of the sesquiterpene lactone parthenolide. Plos One. 4: e8115. PMID 19956548 DOI: 10.1371/journal.pone.0008115  0.68
2009 Jaramillo MC, Frye JB, Crapo JD, Briehl MM, Tome ME. Increased manganese superoxide dismutase expression or treatment with manganese porphyrin potentiates dexamethasone-induced apoptosis in lymphoma cells Cancer Research. 69: 5450-5457. PMID 19549914 DOI: 10.1158/0008-5472.CAN-08-4031  0.68
2007 Chow HH, Hakim IA, Vining DR, Crowell JA, Tome ME, Ranger-Moore J, Cordova CA, Mikhael DM, Briehl MM, Alberts DS. Modulation of human glutathione s-transferases by polyphenon e intervention. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 16: 1662-6. PMID 17684143 DOI: 10.1158/1055-9965.EPI-06-0830  0.68
2006 Tome ME, Johnson DB, Samulitis BK, Dorr RT, Briehl MM. Glucose 6-phosphate dehydrogenase overexpression models glucose deprivation and sensitizes lymphoma cells to apoptosis. Antioxidants & Redox Signaling. 8: 1315-27. PMID 16910779 DOI: 10.1089/ars.2006.8.1315  0.6
2005 Tome ME, Johnson DB, Rimsza LM, Roberts RA, Grogan TM, Miller TP, Oberley LW, Briehl MM. A redox signature score identifies diffuse large B-cell lymphoma patients with a poor prognosis. Blood. 106: 3594-601. PMID 16081686 DOI: 10.1182/blood-2005-02-0487  0.68
2005 Efferth T, Rauh R, Kahl S, Tomicic M, Böchzelt H, Tome ME, Briehl MM, Bauer R, Kaina B. Molecular modes of action of cantharidin in tumor cells. Biochemical Pharmacology. 69: 811-8. PMID 15710358 DOI: 10.1016/j.bcp.2004.12.003  0.6
2005 Tome ME, Briehl MM, Lutz NW. Increasing the antioxidant defense in WEHI7.2 cells results in a more tumor-like metabolic profile. International Journal of Molecular Medicine. 15: 497-501. PMID 15702245  0.68
2004 Tome ME, Lutz NW, Briehl MM. Overexpression of catalase or Bcl-2 alters glucose and energy metabolism concomitant with dexamethasone resistance. Biochimica Et Biophysica Acta. 1693: 57-72. PMID 15276325 DOI: 10.1016/j.bbamcr.2004.05.004  0.68
2004 Butts BD, Tran NL, Briehl MM. Identification of a functional peroxisome proliferator activated receptor response element in the 3' untranslated region of the human bcl-2 gene. International Journal of Oncology. 24: 1305-10. PMID 15067355  0.68
2003 Tome ME, Lutz NW, Briehl MM. Overexpression of catalase or Bcl-2 delays or prevents alterations in phospholipid metabolism during glucocorticoid-induced apoptosis in WEHI7.2 cells. Biochimica Et Biophysica Acta. 1642: 149-62. PMID 14572898 DOI: 10.1016/j.bbamcr.2003.08.002  0.68
2003 Efferth T, Briehl MM, Tome ME. Role of antioxidant genes for the activity of artesunate against tumor cells. International Journal of Oncology. 23: 1231-5. PMID 12964009  0.6
2003 Butts BD, Kwei KA, Bowden GT, Briehl MM. Elevated basal reactive oxygen species and phospho-Akt in murine keratinocytes resistant to ultraviolet B-induced apoptosis. Molecular Carcinogenesis. 37: 149-57. PMID 12884366 DOI: 10.1002/mc.10131  0.68
2002 Dvorakova K, Payne CM, Tome ME, Briehl MM, Vasquez MA, Waltmire CN, Coon A, Dorr RT. Molecular and cellular characterization of imexon-resistant RPMI8226/I myeloma cells. Molecular Cancer Therapeutics. 1: 185-95. PMID 12467213  0.6
2000 Siemankowski LM, Morreale J, Butts BD, Briehl MM. Increased tumor necrosis factor-alpha sensitivity of MCF-7 cells transfected with NAD(P)H:quinone reductase. Cancer Research. 60: 3638-44. PMID 10910079  0.68
Show low-probability matches.